The first Ebola vaccine could be
available in two to six years, experts say but warn a lack of funding
could hamper vital clinical trials.
At
least four new drugs are in the developmental stage in labs across the
U.S. with trials involving primates yielding positive results.
But researchers warn a lack of funding threatens the speed at which the first preventative jab could be available for human use.
Dr Thomas Geisbert of the University of Texas said he believes a vaccine will be approved in the next two to six years.
Dr Geisbert, whose lab is
working on some of the drugs, said: 'There are at least four vaccines
that can protect against Ebola (in monkeys).
'But how do you take this to the next level?'
He said he believes a vaccine will be available from two to six years.
'I hate to say this, but it really depends on financial support for the small companies that develop these vaccines.
'Human studies are expensive and require a lot of government dollars.
No comments:
Post a Comment